|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 47 of 59 found articles
| Title: |
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial |
| Author: |
Zhu, Andrew X Park, Joon Oh Ryoo, Baek-Yeol Yen, Chia-Jui Poon, Ronnie Pastorelli, Davide Blanc, Jean-Frederic Chung, Hyun Cheol Baron, Ari D Pfiffer, Tulio Eduardo Flesch Okusaka, Takuji Kubackova, Katerina Trojan, Jorg Sastre, Javier Chau, Ian Chang, Shao-Chun Abada, Paolo B Yang, Ling Schwartz, Jonathan D Kudo, Masatoshi |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 16 (2015) nr. 7 pages 12 p. |
| Year: |
2015 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 47 of 59 found articles
| << previous | next >> |